Genomic Prediction, Inc. announced it raised $12 Million in an initial filing from an offering of $12 Million

Company

Location

About

LifeView is a cost-effective means to evaluate genetic issues in embryos including chromosome abnormalities, monogenic conditions, and polygenic diseases. Our innovative methodology is entirely unique. We are the first lab to offer polygenic screening in embryos. LifeView represents the next step in preimplantation genetic testing, combining dense, genome-wide genotyping methods with sophisticated validation-focused modeling suitable for the information age.